. 2014 Dec 19;1:32. doi: 10.1186/s40697-014-0032-7
© Martinusen et al.; licensee BioMed Central. 2014
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Figure 1.
Factors balancing the use of an innovator biologic vs. an SEB.